Product Details

Teva-Irbesartan HCTZ

Irbesartan + Hydrochlorothiazide
300 mg + 25 mg
Tablet


DIN/PIN/NPN

02330539

Manufacturer

Teva Canada Limited

Formulary Listing Date

2011-08-04  

Unit Price

0.2184

Amount MOH Pays

0.2184

Coverage Status

General Benefit Chronic-Use Medication

ODB Formulary Therapeutic Classification

Therapeutic Note

NO

ATC Code

C09DA04

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02330539 Teva-Irbesartan HCTZ 0.2184 0.2184
02337444 Sandoz Irbesartan HCT 0.2184 0.2184
02363224 Ran-Irbesartan HCTZ 0.2184 0.2184
02328534 PMS-Irbesartan-HCTZ 0.2184 0.2184
02393026 Mint Irbesartan/HCTZ 0.2184 0.2184
02418258 Jamp-Irbesartan and Hydrochlorothiazide 0.2184 0.2184
02372908 Irbesartan/HCTZ 0.2184 0.2184
02385333 Irbesartan HCT 0.2184 0.2184
02357410 Co Irbesartan/HCT 0.2184 0.2184
02280213 Avalide NA NA
02447894 Auro-Irbesartan HCT 0.2184 0.2184
02387662 Apo-Irbesartan/HCTZ 0.2184 0.2184
 

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph